US 8212010
Sphingosine 1-phosphate antagonism
granted A61KA61K2039/505A61K31/00
Quick answer
US patent 8212010 (Sphingosine 1-phosphate antagonism) held by Expression Drug Designs, LLC expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Expression Drug Designs, LLC
- Grant date
- Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K31/00, A61K31/138, A61K31/235